**Core Concept**
Cowden syndrome is a rare autosomal dominant disorder characterized by multiple benign tumors and increased cancer risk, primarily due to germline mutations in the *PTEN* gene. PTEN encodes a tumor suppressor protein that negatively regulates the PI3K/AKT/mTOR signaling pathway by dephosphorylating PIP3 to PIP2, thereby inhibiting cell growth and proliferation.

**Why the Correct Answer is Right**
PTEN is the primary gene mutated in Cowden syndrome. Loss-of-function mutations in PTEN lead to uncontrolled activation of the PI3K/AKT pathway, resulting in hyperactivation of cell growth, survival, and proliferation. This explains the high incidence of breast, thyroid, and endometrial cancers in affected individuals. The condition is clinically recognized by the presence of trichilemmomas, macrocephaly, and developmental abnormalities.

**Why Each Wrong Option is Incorrect**
Option A: P53 mutations are associated with Li-Fraumeni syndrome, not Cowden syndrome. P53 regulates DNA repair and apoptosis, not PI3K signaling.
Option C: RB gene mutations cause retinoblastoma and other tumors, but not Cowden syndrome. RB is involved in cell cycle control, not PI3K pathway regulation.
Option D: Ras mutations are linked to familial adenomatous polyposis and certain cancers, but not Cowden syndrome. Ras activates MAPK signaling, not PI3K.

**Clinical Pearl / High-Yield Fact**
Remember: **PTEN = PI3K inhibitor**. In Cowden syndrome, PTEN loss leads to PI3K hyperactivity. Always associate PTEN with **thyroid papillomas**, **breast cancer**, and **developmental anomalies**.

✓ Correct Answer: B. PTEN